EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JULY 19, 2023
MINNEAPOLIS – People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
MS is a disease in which the body’s immune system attacks myelin, the fatty white substance that insulates and protects the nerves. Symptoms of MS may include fatigue, numbness, tingling or difficulty walking.
“When it comes to MS treatment, the earlier the better,” said study author Alvaro Cobo-Calvo, MD, PhD, of the Multiple Sclerosis Center of Catalonia and the Autonomous University of Barcelona in Spain. “Our study found that starting treatment within six months after the first symptoms is associated with a lower risk of disability over time.”
For the study, researchers looked at 580 people with a first episode of symptoms, such as tingling, numbness, muscle weakness or problems with balance, who received at least one disease-modifying drug.
Researchers divided participants into three groups: 194 people who had their first treatment with an MS drug within six months after the first episode of symptoms, 192 people who had first treatment between six months and 16 months, and 194 people who had first treatment after more than 16 months.
Researchers monitored people’s disability levels and brain scans for damage to the brain and spinal cord from the disease for an average of 11 years. Disability scores ranged from zero to 10, with higher scores indicating more disability.
The earliest treatment group had a 45% lower risk of reaching a disability score of three by the end of the study than those in the latest treatment group. A score of three indicates people can still walk unassisted but have moderate disability in one of eight areas, such as motor function, vision or thinking skills, or mild disability in three or four areas. A total of 42 people in the earliest treatment group, or 23%, reached a score of three, compared to 75 people, or 43%, in the latest treatment group.
The earliest treatment group also had a 60% lower risk of moving to the next stage of the disease, called secondary progressive MS, than people in the latest treatment group. In this stage, disability gets steadily worse. A total of 14 people in the earliest treatment group, or 7%, were diagnosed with secondary progressive MS compared to 43 people in the latest treatment group, or 23%.
They also found that people with the earliest treatment were 50% more likely to remain stable at their disease level one year after their initial treatment than those in the latest treatment group.
“Altogether, our results support the robustness and effectiveness of very early treatment to halt long-term disability progression, and stress that earlier detection and treatment is encouraged,” Cobo-Calvo said.
Researchers also found that people from the earliest treatment group had a lower disability progression rate and lower severe disability in a self-reported test compared to those in the latest treatment group.
A limitation of the study was that it only included patients between ages 16 to 50 at the time of first symptoms, so the results could not be applied to patients over age 50, or late-onset multiple sclerosis.
The study was supported by the European Regional Development Fund, Carlos III Health Institute, Spanish Multiple Sclerosis Network and the Agency for Management of University and Research Grants in Spain.
Learn more about MS at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram.
When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.
The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube.
END
Treatment at the first signs of MS could mean lower risk of disability later
2023-07-19
(Press-News.org)
ELSE PRESS RELEASES FROM THIS DATE:
Teaching robots to teach other robots
2023-07-19
You’re a poker wizard. A friend knows all about French cuisine. Another friend is a Mozart expert.
The three of you get together and share knowledge about your respective expertise. Each of you leaves learning something from the other two.
People learn a lot by sharing and exchanging information. Can computers do the same with other computers—can robots, in effect, teach other robots how to learn by sharing knowledge?
A team of researchers led by computer science Professor Laurent Itti and one of his Ph.D. students, Yunhao Ge, address this question in ...
Molecular biologists identify framework for understanding RNA editing in a disease-causing parasite
2023-07-19
As molecular biologists at Boston University and as husband and wife, Ruslan Afasizhev and Inna Afasizheva, have worked together for decades. Together, they have published dozens of papers on the mechanics of mitochondrial DNA and RNA in a single-celled, disease-causing parasite called Trypanosoma brucei. Now, years of breakthroughs have led to their latest paper published in Science, which provides a detailed look at a mystifying process called RNA editing and could potentially help treat a deadly disease.
In ...
Picturing where wildlands and people meet at a global scale
2023-07-19
Researchers led by a team at the University of Wisconsin–Madison have created the first tool to map and visualize the areas where human settlements and nature meet on a global scale. The tool, which was part of a study recently published in Nature, could improve responses to environmental conflicts like wildfires, the spread of zoonotic diseases and loss of ecosystem biodiversity.
These areas where people and wildlands meet are called the wildland-urban interface, or WUI for short. More technically, a WUI (pronounced “woo-ee”) describes anywhere that has at least one house per 40 acres and is also 50% covered by wildland ...
Using new method, study highlights physician turnover trend
2023-07-19
Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year. The causes of this trend are not known, but warrant further investigation, according to the researchers.
The study, published July 11 in the Annals of Internal Medicine, also found that the first three quarters of 2020 (the start of the COVID-19 pandemic in the United States) were not associated with higher turnover. However, more data are needed to fully understand turnover trends related to COVID-19.
Whether doctors ...
Winery experiences affected by more than what is in your glass
2023-07-19
New research from the University of British Columbia's Okanagan campus has determined that enjoying a tasting at a winery goes well beyond the sip.
Professor Annamma Joy, with UBCO’s Faculty of Management, conducts research in the area of consumer behaviour and branding with a special focus on luxury brands, fashion brand experiences, wineries and wine tourism.
Dr. Joy, along with her collaborators and students, studied several Okanagan wineries over a three-year period to comprehensively document the experiences ...
Researchers use mass spectrometry to explore antimicrobial resistance
2023-07-19
Laura-Isobel McCall, Ph.D., and Zhibo Yang, Ph.D., co-principal investigators and associate professors of chemistry and biochemistry in the Dodge Family College of Arts and Sciences at the University of Oklahoma, have been awarded a prestigious R01 grant from the National Institutes of Health for their project, “Novel single-cell mass spectrometry to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure.”
“Our project builds upon Dr. ...
Novel therapeutic strategy against melanoma: combined targeting of hedgehog signaling and BRD4
2023-07-19
“This evidence strengthens the relevance of the findings by Pietrobono et al., shedding light on the potential application of SMO inhibitors in concert with BRD4 inhibitors.”
BUFFALO, NY- July 19, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma.”
The Hedgehog-GLI (HH/GLI) pathway is aberrantly activated in several types of cancer. Canonical HH/ GLI pathway is triggered by binding of HH ligands to the twelve-pass transmembrane receptor Patched 1 (PTCH1), which retrieves its inhibition ...
Large study finds small associations between systemic inflammation and later dementia
2023-07-19
A study of data from about 500,000 people in the UK Biobank has uncovered small but statistically significant associations between signs of systemic inflammation and later risk of dementia. Dr. Krisztina Mekli of The University of Manchester, UK, and colleagues present these findings in the open-access journal PLOS ONE on July 19, 2023.
Millions of people around the world have Alzheimer’s disease or other types of dementia, and researchers are working to tease out the complex mechanisms behind these conditions. Prior research has suggested that inflammation—activation of the body’s innate immune system—may ...
STEM instructors who are women drive disclosure of concealable stigmatized identities to undergraduates
2023-07-19
Women working as STEM instructors are more likely than men in the same profession to disclose to their undergraduate students identities which could carry stigma, such as depression or growing up in a low-income household. In the new study, published July 19, 2023 in the open-access journal PLOS ONE, Carly Busch of Arizona State University, USA, and colleagues suggest that these decisions to disclose may be in order to act as role models for students.
Concealable stigmatized identities (CSIs) are identities that ...
Researchers used a LEGO robotics kit as a cheap, effective way to purify self-assembling DNA origami
2023-07-19
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0283134
Article Title: Gradient-mixing LEGO robots for purifying DNA origami nanostructures of multiple components by rate-zonal centrifugation
Author Countries: USA
Funding: The research in Hariadi lab was supported by the National Institutes of Health Director’s New Innovator Award (1DP2AI144247), National Science Foundation SemiSynBio II (2027215), and Arizona Biomedical Research Consortium (ADHS17-00007401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. END ...